Brief: Landos Biopharma Inc Shares Open About 18.8% Below IPO Price In Debut On Nasdaq
Feb 4 (Reuters) -
* LANDOS BIOPHARMA INC SHARES OPEN AT $13.00 ON DEBUT ON
NASDAQ
VERSUS IPO PRICE OF $16.00/SHARE
Further company coverage: LABP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Landos Biopharma
See all newsLandos Biopharma Inc expected to post a loss of 100 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma